Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Chunlei Wu, Denhua Ma & Yu Chen. (2021) Association of Pulse Pressure Difference and Diabetes Mellitus in Chinese People: A Cohort Study. International Journal of General Medicine 14, pages 6601-6608.
Read now
Read now
Weijing Wu, Ju Qiu, Aili Wang & Zaigui Li. (2020) Impact of whole cereals and processing on type 2 diabetes mellitus: a review. Critical Reviews in Food Science and Nutrition 60:9, pages 1447-1474.
Read now
Read now
Articles from other publishers (28)
Nikolaos Kakaletsis, George Ntaios, Haralampos Milionis, Athanasios D. Protogerou, Anastasia Karagiannaki, Ioanna Chouvarda, Vasiliki Dourliou, Ioannis Ladakis, Georgia Kaiafa, Stylianos Daios, Michael Doumas & Christos Savopoulos. (2023) Time of blood pressure in target range in acute ischemic stroke. Journal of Hypertension 41:2, pages 303-309.
Crossref
Crossref
Shahid Bashir, Ali Mir, Nouf Altwaijri, Mohammad Uzair, Amani Khalil, Rania Albesher, Roaa Khallaf, Saad Alshahrani & Turki Abualait. (2023) Neuroeconomics of decision-making during COVID-19 pandemic. Heliyon 9:2, pages e13252.
Crossref
Crossref
Sachiko Otake, Asako Sato & Tetsuya Babazono. (2021) Prevalence and predictors of atrial fibrillation in Japanese patients with type 2 diabetes. Diabetology International 13:1, pages 101-107.
Crossref
Crossref
Tomoyuki Saito, Hirotoshi Ohmura, Shuko Nojiri & Hiroyuki Daida. (2020) Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study. Journal of Pharmaceutical Health Care and Sciences 6:1.
Crossref
Crossref
Yali Zhang, Rong Shi, Liang Yu, Liping Ji, Min Li & Fan Hu. (2020) Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes. Diabetes Therapy 11:9, pages 2057-2073.
Crossref
Crossref
C. Mestral, S. Stringhini, I. Guessous & F. R. Jornayvaz. (2019) Thirteen‐year trends in the prevalence of diabetes in an urban region of Switzerland: a population‐based study. Diabetic Medicine 37:8, pages 1374-1378.
Crossref
Crossref
David Spirk, Sarah Noll, Michel Burnier, Stefano Rimoldi, Georg Noll & Isabella Sudano. (2020) First Line CombinAtion Therapy in the Treatment of Stage II and III Hypertension (FLASH). Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Hirokatsu Niwa, Kiyohiko Takahashi, Midori Dannoura, Kazuno Oomori, Arina Miyoshi, Toshihiro InadaHideaki Miyoshi. (2019) The Association of Cardio-Ankle Vascular Index and Ankle-Brachial Index with Macroangiopathy in Patients with Type 2 Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis 26:7, pages 616-623.
Crossref
Crossref
Andréa Cristina Sousa, Thiago Veiga Jardim, Thiago Olivera Costa, Fabrício Galdino Magalhães, Marcos Paulo Marinho Montelo, Weimar K. Barroso Souza, Paulo César Brandão Veiga Jardim & Ana Luiza Lima Sousa. (2017) Hypertensive diabetic patients: incidence of cardiovascular and renal outcomes in a historical cohort over 11 years. Diabetology & Metabolic Syndrome 9:1.
Crossref
Crossref
Neda Zafari, Samaneh Asgari, Mojtaba Lotfaliany, Amirreza Hadaegh, Fereidoun Azizi & Farzad Hadaegh. (2017) Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Scientific Reports 7:1.
Crossref
Crossref
Yukako Tatsumi & Takayoshi Ohkubo. (2017) Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese. Hypertension Research 40:9, pages 795-806.
Crossref
Crossref
Michael W. StewartMichael W. Stewart. 2017. Diabetic Retinopathy. Diabetic Retinopathy
1
27
.
Om P Ganda & Joanna Mitri. (2016) Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes. Current Cardiology Reports 18:11.
Crossref
Crossref
Gustavo SaposnikS. Claiborne Johnston. (2014) Decision Making in Acute Stroke Care. Stroke 45:7, pages 2144-2150.
Crossref
Crossref
Carola A Huber, Thomas D Szucs, Roland Rapold & Oliver Reich. (2013) Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health 13:1.
Crossref
Crossref
Yasuo Haruyama, Hiroshi Fukuda, Tomoe Arai & Takashi Muto. (2013) Change in Lifestyle through Health Promotion Program without Face‐to‐Face Intervention in a Large‐scale Japanese Enterprise. Journal of Occupational Health 55:2, pages 74-83.
Crossref
Crossref
A. Kaiser, P. Vollenweider, G. Waeber & P. Marques‐Vidal. (2012) Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. Diabetic Medicine 29:2, pages 190-197.
Crossref
Crossref
Justin B. Echouffo-Tcheugui, Modele O. Ogunniyi & André P. Kengne. (2011) Estimation of Absolute Cardiovascular Risk in Individuals with Diabetes Mellitus: Rationale and Approaches. ISRN Cardiology 2011, pages 1-5.
Crossref
Crossref
Yasuo Haruyama. 2011. Asian Perspectives and Evidence on Health Promotion and Education. Asian Perspectives and Evidence on Health Promotion and Education
214
222
.
S. Harrap, A. Patel & J. Chalmers. (2009) Nuevas perspectivas en el tratamiento del paciente diabético. Estudio ADVANCE. Hipertensión y Riesgo Vascular 26:2, pages 80-83.
Crossref
Crossref
José Ramón González-Juanatey, Eduardo Alegría Ezquerra, Ramón Gomis Barberá, María Jesús Salvador Taboada, Lilian Grigorian Shamagian, José Antonio Casasnovas Lenguas, Víctor López García-Aranda, Domingo Acosta Delgado, Javier Salvador Rodríguez, Antonio Hernández Mijares & Arantxa Matalí Gilarranz. (2009) Disfunción eréctil como marcador de vasculopatía en la diabetes mellitus tipo 2 en España. Estudio DIVA. Medicina Clínica 132:8, pages 291-297.
Crossref
Crossref
Yasuo Haruyama, Takashi Muto, Makiko Nakade, Emiko Kobayashi, Kaori Ishisaki & Akiko Yamasaki. (2009) Fifteen-Month Lifestyle Intervention Program to Improve Cardiovascular Risk Factors in a Community Population in Japan. The Tohoku Journal of Experimental Medicine 217:4, pages 259-269.
Crossref
Crossref
John Chalmers, Rohina Joshi, Andre Pascal Kengne, Toshiharu Ninomiya, Yufang Bi, Severine Bompoint, Laurent Billot & Anushka Patel. (2008) Efficacité et tolérance de lʼassociation fixe perindopril / indapamide dans le diabète de type 2: résultats de lʼétude ADVANCE. Journal of Hypertension 26:Suppl 3, pages S23-S30.
Crossref
Crossref
John Chalmers, Rohina Joshi, Andre Pascal Kengne, Toshiharu Ninomiya, Yufang Bi, Severine Bompoint, Laurent Billot & Anushka Patel. (2008) Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Journal of Hypertension 26:Suppl 3, pages S21-S27.
Crossref
Crossref
Eberhard Ritz. (2007) Total Cardiovascular Risk Management. The American Journal of Cardiology 100:3, pages S53-S60.
Crossref
Crossref
. (2007) Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia???Pacific region. Journal of Hypertension 25:6, pages 1205-1213.
Crossref
Crossref
Antonio M. GottoJr.Jr.. (2007) Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus. The American Journal of Cardiology 99:4, pages 3-5.
Crossref
Crossref
Hiroshi FUKUDA, Yasuo HARUYAMA, Makiko NAKADE & Takashi MUTO. (2007) Relationship between Lifestyle and Change of Cardiovascular Risk Factors Based on a Five-year Follow-up of Employees in Japan. Industrial Health 45:1, pages 56-61.
Crossref
Crossref